Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 27, 2017 Filed Dec 28, 2017 21:31 UTC |
Silva Paul MSVP & Corp Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,289 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-17-067583 · doc4.xml · derivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,289 Underlying: Common Stock · 1,289 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/05/2014. Read SEC document |
| December 27, 2017 Filed Dec 28, 2017 21:31 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 1,289 | $152.31 | $196,327.59 |
DisclosureSEC source: 0001209191-17-067583 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,634 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Read SEC document |
| December 27, 2017 Filed Dec 28, 2017 21:31 UTC |
Silva Paul MSVP & Corp Controller
|
Exercise / conversionCommon Stock | 1,289 | $77.31 | $99,652.59 |
DisclosureSEC source: 0001209191-17-067583 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2017 Filed Jan 17, 2018 21:42 UTC |
SACHS BRUCE IDirector
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-003972 · doc5.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,398 F1 · kind: Represents a gift to a charitable foundation. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 23:30 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 5,198 | $143.39 | $745,341.22 |
DisclosureSEC source: 0001209191-17-065094 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,497 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $143.39 (range $142.90 to $143.85). Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 23:30 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 12,134 | $142.21 | $1,725,576.14 |
DisclosureSEC source: 0001209191-17-065094 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,695 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $142.21 (range $141.86 to $142.79). Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 23:30 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 87,578 | $141.35 | $12,379,150.30 |
DisclosureSEC source: 0001209191-17-065094 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,829 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $141.35 (range $140.86 to $141.85). Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 23:30 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 20,090 | $140.31 | $2,818,827.90 |
DisclosureSEC source: 0001209191-17-065094 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,407 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $140.31 (range $139.85 to 140.84). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:37 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 221 | $147.29 | $32,551.09 |
DisclosureSEC source: 0001209191-17-061506 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,952 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:41 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 83 | $147.29 | $12,225.07 |
DisclosureSEC source: 0001209191-17-061524 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,710 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:44 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 7 | $147.29 | $1,031.03 |
DisclosureSEC source: 0001209191-17-061525 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,888 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:46 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 23 | $147.29 | $3,387.67 |
DisclosureSEC source: 0001209191-17-061526 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,634 F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:48 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 206 | $149.80 | $30,858.80 |
DisclosureSEC source: 0001209191-17-061528 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,011 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $149.80 (range $149.28 to $150.25). F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:48 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 100 | $147.71 | $14,771.00 |
DisclosureSEC source: 0001209191-17-061528 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,217 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 15, 2017 Filed Dec 6, 2017 22:40 UTC Amendment |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 48 | $147.29 | $7,069.92 |
DisclosureSEC source: 0001209191-17-064229 · doc4a.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,952 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. F2 · shares: This amendment corrects an error by our external equity plan administrator and reduces the number of shares sold from 221 shares to 48 shares. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:15 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,250 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-17-059636 · doc4.xml · derivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 Underlying: Common Stock · 4,250 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/5/2014. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:15 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 4,250 | $148.17 | $629,722.50 |
DisclosureSEC source: 0001209191-17-059636 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,952 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:15 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,250 | $77.31 | $328,567.50 |
DisclosureSEC source: 0001209191-17-059636 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:26 UTC |
SMITH IAN FEVP, COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,250 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-17-059638 · doc4.xml · derivative · entry 7 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 Underlying: Common Stock · 4,250 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/5/2014. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:26 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 4,250 | $150.00 | $637,500.00 |
DisclosureSEC source: 0001209191-17-059638 · doc4.xml · nonDerivative · entry 4 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,888 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:26 UTC |
SMITH IAN FEVP, COO
|
Exercise / conversionCommon Stock | 4,250 | $77.31 | $328,567.50 |
DisclosureSEC source: 0001209191-17-059638 · doc4.xml · nonDerivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,594 | $0.00 Strike: $109.14 | $0.00 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · derivative · entry 8 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,969 Underlying: Common Stock · 3,594 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/3/2015. Read SEC document |
| November 03, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 3,594 | $144.69 | $520,015.86 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · nonDerivative · entry 6 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $144.69 (range $144.19 to $144.90). Read SEC document |
| November 03, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionCommon Stock | 3,594 | $109.14 | $392,249.16 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · nonDerivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:12 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,073 | $0.00 Strike: $93.51 | $0.00 |
DisclosureSEC source: 0001209191-17-059633 · doc4.xml · derivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,073 shares Expires 2026-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:12 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 7,073 | $143.05 | $1,011,792.65 |
DisclosureSEC source: 0001209191-17-059633 · doc4.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,953 F1 · kind: Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:12 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionCommon Stock | 7,073 | $93.51 | $661,396.23 |
DisclosureSEC source: 0001209191-17-059633 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:23 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,330 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-059637 · doc4.xml · derivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,289 Underlying: Common Stock · 2,330 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/3/2017. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:23 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 2,330 | $149.50 | $348,335.00 |
DisclosureSEC source: 0001209191-17-059637 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,809 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:23 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 2,330 | $86.52 | $201,591.60 |
DisclosureSEC source: 0001209191-17-059637 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:26 UTC |
SMITH IAN FEVP, COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,155 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-17-059638 · doc4.xml · derivative · entry 6 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,397 Underlying: Common Stock · 2,155 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/2/2016. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:26 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 2,155 | $150.00 | $323,250.00 |
DisclosureSEC source: 0001209191-17-059638 · doc4.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,888 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 22:26 UTC |
SMITH IAN FEVP, COO
|
Exercise / conversionCommon Stock | 2,155 | $91.05 | $196,212.75 |
DisclosureSEC source: 0001209191-17-059638 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,796 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · derivative · entry 7 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,164 Underlying: Common Stock · 1,796 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/2/2016. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 300 | $145.89 | $43,767.00 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · nonDerivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $145.89 (range $145.63 to $146.04). Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,096 | $144.89 | $158,799.44 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · nonDerivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,724 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $144.89 (range $144.48 to $145.18). Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 400 | $143.54 | $57,416.00 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,820 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $143.54 (range $142.98 to $143.81). F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 22:50 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionCommon Stock | 1,796 | $91.05 | $163,525.80 |
DisclosureSEC source: 0001209191-17-059474 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 100 | $149.34 | $14,934.00 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 8 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,710 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 1,000 | $148.35 | $148,350.00 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 7 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,810 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $148.35 (range $148.19 to $148.70). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 2,200 | $147.70 | $324,940.00 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,810 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $147.70 (range $147.18 to $148.15). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 3,200 | $146.53 | $468,896.00 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,010 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $146.53 (range $146.16 to $147.14). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 12,438 | $145.26 | $1,806,743.88 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,210 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 17,362 | $144.47 | $2,508,288.14 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,648 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.90 to $144.89). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 2,800 | $143.49 | $401,772.00 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,010 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $143.49 (range $142.87 to $143.85). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:12 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 900 | $142.40 | $128,160.00 |
DisclosureSEC source: 0001209191-17-058477 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,810 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.70). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 200 | $149.34 | $29,868.00 |
DisclosureSEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 8 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,400 | $148.40 | $207,760.00 |
DisclosureSEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 7 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,624 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $148.40 (range $148.19 to $148.70). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 3,400 | $147.75 | $502,350.00 |
DisclosureSEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 6 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,024 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $147.75 (range $147.18 to $148.15). Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 22:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 4,700 | $146.52 | $688,644.00 |
DisclosureSEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $146.52 (range $146.16 to $147.14). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.